Literature DB >> 19268029

An oral calcitonin gene-related peptide receptor antagonist for acute migraine management: sign of a possible new chapter in headache medicine.

Ivan Garza1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19268029     DOI： 10.1007/s11910-009-0014-9

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


× No keyword cloud information.
  10 in total

Review 1.  Migraine--current understanding and treatment.

Authors:  Peter J Goadsby; Richard B Lipton; Michel D Ferrari
Journal:  N Engl J Med       Date:  2002-01-24       Impact factor: 91.245

2.  The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers.

Authors:  K A Petersen; S Birk; L H Lassen; C Kruuse; O Jonassen; L Lesko; J Olesen
Journal:  Cephalalgia       Date:  2005-02       Impact factor: 6.292

3.  Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.

Authors:  M D Ferrari; K I Roon; R B Lipton; P J Goadsby
Journal:  Lancet       Date:  2001-11-17       Impact factor: 79.321

4.  CGRP may play a causative role in migraine.

Authors:  L H Lassen; P A Haderslev; V B Jacobsen; H K Iversen; B Sperling; J Olesen
Journal:  Cephalalgia       Date:  2002-02       Impact factor: 6.292

Review 5.  Answers to frequently asked questions about migraine.

Authors:  Ivan Garza; Jerry W Swanson
Journal:  Mayo Clin Proc       Date:  2006-10       Impact factor: 7.616

6.  Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides.

Authors:  A S Zagami; P J Goadsby; L Edvinsson
Journal:  Neuropeptides       Date:  1990-06       Impact factor: 3.286

7.  The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

Authors:  P J Goadsby; L Edvinsson
Journal:  Ann Neurol       Date:  1993-01       Impact factor: 10.422

8.  Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

Authors:  Jes Olesen; Hans-Christoph Diener; Ingo W Husstedt; Peter J Goadsby; David Hall; Ulrich Meier; Stephane Pollentier; Lynna M Lesko
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

9.  Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system.

Authors:  P J Goadsby; L Edvinsson; R Ekman
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

10.  Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine.

Authors:  A Doenicke; J Brand; V L Perrin
Journal:  Lancet       Date:  1988-06-11       Impact factor: 79.321
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.